As of today (2024-04-25), Landos Biopharma's share price is $22.49. Landos Biopharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $10.20. Hence, Landos Biopharma's Price to Tangible Book Ratio of today is 2.20.
The historical rank and industry rank for Landos Biopharma's Price-to-Tangible-Book or its related term are showing as below:
LABP'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.36 Med: 0.51 Max: 2.53
Current: 2.2
During the past 6 years, Landos Biopharma's highest Price to Tangible Book Ratio was 2.53. The lowest was 0.36. And the median was 0.51.
LABP's Price-to-Tangible-Book is ranked better than 58.03% of 1220
companies
in the Biotechnology industry
Industry Median: 2.67
vs LABP: 2.20
A closely related ratio is called PB Ratio. As of today, Landos Biopharma's share price is $22.49. Landos Biopharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was $10.20. Hence, Landos Biopharma's P/B Ratio of today is 2.20.
Landos Biopharma Price-to-Tangible-Book Historical Data
The historical data trend for Landos Biopharma's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Landos Biopharma's Price-to-Tangible-Book
For the Biotechnology subindustry, Landos Biopharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Landos Biopharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Landos Biopharma's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Landos Biopharma's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Landos Biopharma Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Landos Biopharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Landos Biopharma (Landos Biopharma) Business Description
Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. It has several active development programs, each discovered internally, targeting novel pathways at the interface of immunity and metabolism. It operates in one reportable segment of operations and manages.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LABP has been successfully added to your 